2T3-26633-63055
4 vaccinations
7 coded responses
44 check-ins
7 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 750 / TX
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-21
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2020-12-28
- 2021-01-02
-
2021-01-09
Survey response — day 21, dose 1MedDRA: Cough, Fatigue, Myalgia, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough congestion runny nose fatigue muscle achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — day 21, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-18
Dose 2 — Pfizer-BioNTech
- 2021-01-18
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Fatigue or tirednessAdult check-in
- 2021-01-21
- 2021-01-22
- 2021-01-24
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-17
- 2021-02-17
- 2021-02-22
- 2021-03-01
-
2021-04-19
Survey response — 3 months, dose 2MedDRA: Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sinus infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-17
- 2021-07-19
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Swollen lymphnodes in the underarmMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: FairFree text: Swelling in the under armMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Swelling under the arm- same side as injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-08
- 2021-10-15
- 2021-10-22
-
2021-10-29
Survey response — day 28, dose 3MedDRA: Depression — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Major depressionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Report sent to call center — day 28, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-01
- 2021-11-07
- 2021-11-12
- 2021-12-31
-
2022-07-18
Dose 4 — Pfizer-BioNTech
-
2022-07-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2022-07-20
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-07-21
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2022-07-21
Report sent to call center — days 1–6 daily, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-22
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2022-07-22
Call successfulDoes not wish to fill out VAERS report
-
2022-07-22
Call successfulDoes not wish to fill out VAERS report
-
2022-07-22
Call successfulDoes not wish to fill out VAERS report
-
2022-07-22
Call successfulDoes not wish to fill out VAERS report
- 2022-07-23
- 2022-07-25
- 2022-08-01
- 2022-08-10
- 2022-08-15
- 2022-08-29
-
2022-10-17
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: COVID 19MedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-10-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-07-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | Successful 2022-07-22 |
Does not wish to fill out VAERS report |
| 2021-04-19 | Successful 2022-07-22 |
Does not wish to fill out VAERS report |
| 2021-10-29 | Successful 2022-07-22 |
Does not wish to fill out VAERS report |
| 2022-07-21 | Successful 2022-07-22 |
Does not wish to fill out VAERS report |
| 2022-10-17 | Successful 2022-10-18 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 1 — day 21, dose 1
Symptoms: Cough congestion runny nose fatigue muscle aches
Release 7 — 3 months, dose 2
Symptoms: Sinus infection
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymphnodes in the underarm
Systemic reaction (other): Swelling in the under arm
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling under the arm- same side as injection site
Release 10 — day 28, dose 3
Symptoms: Major depression
Release 12 — 3 months, dose 4
Symptoms: COVID 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release